Activating cells within the body to restore or repair the underlying causes of hearing loss and multiple sclerosis We are a clinical-stage biotechnology company focused on restoring function – first in hearing loss and then in multiple sclerosis – by developing therapeutics that activate a person’s innate regenerative potential within the body. Our proprietary approach, progenitor cell activation (PCA), uses small molecules to activate progenitor cells within the body to create functional tissue. Our initial therapeutic focus is sensorineural hearing loss (SNHL), which accounts for 90 percent of all hearing loss. SNHL is typically caused by the permanent loss of sensory hair cells in the cochlea within the ear. FX-322, our lead product candidate, is designed to regenerate hair cells through the activation of progenitor cells already present in the cochlea. Applying the same underlying science and approach we use to regenerate sensory hair cells in the inner ear, Frequency also seeks to activate existing progenitor cells in patients with multiple sclerosis to remyelinate axons and restore signal transmission. Our scientists are following early restorative signals in preclinical studies. Interested in joining our team? Explore careers © 2021 Frequency Therapeutics Open Positions Contact Privacy Policy Terms & Conditions

Skip to main navigation Utility PATIENTS CAREERS CONTACT US Corporate Governance Governance Documents Corporate Governance Guidelines Insider Trading Compliance Policy Code of Business Conduct and Ethics Committee Charters Compensation Committee Charter Nominating and Corporate Governance Committee Charter Audit Committee Charter Committee Composition AUDIT COMPENSATION NOMINATING AND GOVERNANCE Tim Barberich Marc Cohen Cynthia Feldmann Michael Huang Robert Langer Joel Marcus = Chairperson = Member = Financial Expert = Lead Director MEET OUR LEADERSHIP TEAM Interested in joining our team? Explore careers © 2021 Frequency Therapeutics Open Positions Contact Privacy Policy Terms and conditions